Literature DB >> 28654190

Interobserver Variability in Scoring Liver Biopsies with a Diagnosis of Alcoholic Hepatitis.

Bela Horvath1, Daniela Allende1, Hao Xie2, John Guirguis3, Jennifer Jeung1, James Lapinski1, Deepa Patil1, Arthur J McCullough3, Srinivasan Dasarathy3, Xiuli Liu4.   

Abstract

BACKGROUND: Alcoholic hepatitis (AH) is one of the most severe forms of alcoholic liver disease. Recently, a histologic scoring system for predicting prognosis in this patient cohort was proposed as Alcoholic Hepatitis Histologic Score (AHHS). We aimed to assess interobserver variability in recognizing histologic features of AH and the effect of this variability on the proposed AHHS categories.
METHODS: Hematoxylin-eosin- and trichrome-stained slides from 32 patients diagnosed with AH with liver biopsies within 1 month of presentation (2000 to 2015) were reviewed by 5 pathologists including 3 liver pathologists and 2 gastrointestinal (GI) pathologists masked to the clinical findings or outcome. Histologic features of AH were assessed, the AHHS was calculated, and an AHHS category (mild, moderate, severe) was assigned. The Fleiss' kappa coefficient (κ) analysis was performed to determine the interobserver agreement.
RESULTS: A slight-to-moderate level of interobserver agreement existed among 5 reviewers on histopathologic features of AH with κ value ranging from 0.20 (95% confidence interval (CI): 0.03 to 0.46, megamitochondria) to 0.52 [95% CI: 0.40 to 0.68, polymorphonuclear leukocyte (PMN) infiltration]. There was only a fair level of agreement in assigning AHHS category (κ = 0.33, 95% CI: 0.20 to 0.51). While overall fibrosis and neutrophilic inflammation were comparably evaluated by 3 liver pathologists and 2 GI pathologists, bilirubinostasis and megamitochondria were more consistently diagnosed by liver pathologists. Overall, 18 of 32 (56%) were uniformly assigned to an AHHS category by all liver pathologists with a κ value of 0.40 (95% CI: 0.22 to 0.60).
CONCLUSIONS: In general, features of AH can be recognized with a slight-to-moderate level of interobserver agreement and there was fair interobserver agreement on assigning an AHHS category. Significant interobserver variability among pathologists revealed by the current study can limit its usefulness in everyday clinical practice.
Copyright © 2017 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcoholic Hepatitis; Interobserver Variability; Liver Biopsy

Mesh:

Substances:

Year:  2017        PMID: 28654190      PMCID: PMC6309429          DOI: 10.1111/acer.13438

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  6 in total

Review 1.  Liver biopsy for assessment of chronic liver diseases: a synopsis.

Authors:  Aqib B Chowdhury; Kosha J Mehta
Journal:  Clin Exp Med       Date:  2022-02-22       Impact factor: 3.984

2.  Quantitative and qualitative liver CT: imaging feature association with histopathologically confirmed hepatic cirrhosis.

Authors:  Julian G Rubino; Amir Reza Nasirzadeh; Christian B van der Pol; Kiret Dhindsa; Andrew D Chung
Journal:  Abdom Radiol (NY)       Date:  2022-05-18

Review 3.  Liver Biopsy in Patients With Alcohol-Associated Liver Disease With Acute-on-Chronic Liver Failure.

Authors:  Loretta Jophlin; Ashwani K Singal
Journal:  J Clin Exp Hepatol       Date:  2021-08-14

4.  Histologic parameter score does not predict short-term survival in severe alcoholic hepatitis.

Authors:  Margaux Dubois; Amedeo Sciarra; Eric Trépo; Astrid Marot; Joan Saldarriaga; Christophe Moreno; Christine Sempoux; Pierre Deltenre
Journal:  United European Gastroenterol J       Date:  2020-08-10       Impact factor: 4.623

5.  Restricted immunological and cellular pathways are shared by murine models of chronic alcohol consumption.

Authors:  Alyx Vogle; Tongqi Qian; Shijia Zhu; Elizabeth Burnett; Holger Fey; Zhibin Zhu; Ali Keshavarzian; Maliha Shaikh; Yujin Hoshida; Miran Kim; Costica Aloman
Journal:  Sci Rep       Date:  2020-02-12       Impact factor: 4.379

6.  Murine Models of Alcohol Consumption: Imperfect but Still Potential Source of Novel Biomarkers and Therapeutic Drug Discovery for Alcoholic Liver Disease.

Authors:  Khaled Alharshawi; Costica Aloman
Journal:  J Cell Immunol       Date:  2021
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.